Odds ratios with 95% confidence intervals for colon cancer and selective cyclooxygenase-2 (COX-2) inhibitors, and over the counter nonsteroidal anti-inflammatory drugs (OTC NSAIDS). This evidence concerns the gene PTGS2 and colonic neoplasm.